Clinical Trial Update: Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial of imatinib in dermatofibrosarcoma protuberans completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatofibrosarcoma Protuberans

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Sarcoma Alliance for Research through Collaboration | Conditions: Dermatofibrosarcoma Protuberans | Phase 2 | Status: COMPLETED | Results posted: 2012-03-29